Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Evaluation of Risk Factors for Pseudoexfoliation and Progression to Glaucoma: A Longitudinal Epidemiological Study

Caleb Shumway; Karen Curtin; Sam Taylor; Chase Paulson; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1994. doi:

Cornea September 2017

Topical Cross-Linked HA-Based Hydrogel Accelerates Closure of Corneal Epithelial Defects and Repair of Stromal Ulceration in Companion Animals

PDF

David L. Williams; Barbara M. Wirostko; Glenwood Gum; Brenda K. Mann
TAGS: cornea, corneal epithelial defect, dog, domestic, healing process, hyaluronic acid, hydrogel, ulcer, wound healing, cats, adaptive testing
Invest. Ophthalmol. Vis. Sci.. 2017; 58(11):4616-4622. doi: https://doi.org/10.1167/iovs.16-20848

ARVO Annual Meeting Abstract June 2017

The effect of crosslinked CMHA-S gel drops on in vivo corneal chemical burns

Cassie Sprague; Barbara M Wirostko; Brenda Mann; Jennifer McDaniel; Gina L Griffith

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):131. doi:

ARVO Annual Meeting Abstract June 2017

Efficacy and safety of an Iontophoresis platform to control post cataract inflammation and pain

Barbara M Wirostko; Carol Marie Assang; Brenda Mann; Stephen From; Michael Raizman

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1081. doi:

ARVO Annual Meeting Abstract June 2017

Finite-element design of a carboxymethylated hyaluronic acid (CMHA-S) ocular bandage

Jourdan Colter; nathaniel cady; Brenda Mann; Barbara M Wirostko; Brittany Coats

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1976. doi:

ARVO Annual Meeting Abstract June 2017

Risk of inguinal hernia (IH) is increased in male patients with exfoliation syndrome: The Utah Project on Exfoliation Syndrome (UPEXS).

Brian Besch; R. Rand Allingham; Jathine Wong; Karen Curtin; Robert Ritch; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3721. doi:

ARVO Annual Meeting Abstract June 2017

Carboxymethylated Hyaluronic acid (CMHA-S)-based Ocular Delivery of Antibiotics

Hee-Kyoung Lee; Shirley Luo; Barbara M Wirostko; Brenda Mann

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4119. doi:

ARVO Annual Meeting Abstract September 2016

Sustained Retinal Concentrations of OHR3031 Achieved with Intravitreal Injection of a Biodegradable Microparticle Formulation to Rabbits

Marlene Woodruff Modi; Barbara M Wirostko; Robert Jennings; Laxma Reddy; Nikita Malavia; Alisha Simonian; Istvan Szinai; Glenn Stoller

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):770. doi:

ARVO Annual Meeting Abstract September 2016

Crosslinked carboxymethylated hyaluronic acid (CMHA-S)-based ocular sustained delivery of antibiotics

Hee-Kyoung Lee; Benjamin Ham; Shirley Luo; Brittany Coats; Nathaniel Cady; Brenda Mann; MaryJane Rafii; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1124. doi:

ARVO Annual Meeting Abstract September 2016

Design optimization to improve retention of a carboxymethylated hyaluronic acid (CMHA-S) drug-delivery device

Jourdan Colter; Nathaniel Cady; Hee-Kyoung Lee; Brenda Mann; Barbara M Wirostko; Brittany Coats

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1127. doi:

ARVO Annual Meeting Abstract September 2016

Human growth hormone released from a biocompatible hyaluronic acid biomaterial modulates wound healing in an in vivo corneal chemical burn model

Gina L Griffith; Barbara M Wirostko; Hee-Kyoung Lee; Anthony James Johnson; David O Zamora

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1265. doi:

ARVO Annual Meeting Abstract September 2016

Association of Pelvic Organ Prolapse (POP) and Exfoliation Syndrome in Utah Medicare Beneficiaries

Samuel Crandall Thomas; Karen Curtin; Brian M Besch; Rand R Allingham; Robert Ritch; Gregory S Hageman; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2619. doi:

ARVO Annual Meeting Abstract June 2015

Assessing ocular hyaluronidase to develop a hyaluronan-based polymer drug delivery platform

Randy Christopher Bowen; Won Yong Lee; David W Grainger; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1295. doi:

ARVO Annual Meeting Abstract June 2015

Safety Assessment of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl Hyaluronic Acid (CMHA) Polymer in a Rabbit Ocular Surface Model.

Glenwood G Gum; Barbara M Wirostko; MaryJane Rafii; Vatsala Naageshwaran; Matthew Lyulkin; Ruebuen Merideth; Brenda Mann

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1297. doi:

ARVO Annual Meeting Abstract June 2015

Sustained Delivery of rHGH via a Novel, Biodegradable, Hyaluronic Acid (HA) Polymer Film

Barbara M Wirostko; Gina L Griffith; David O Zamora; MaryJane Rafii; Anthony James Johnson; Hee-Kyoung Lee

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):262. doi:

ARVO Annual Meeting Abstract June 2015

Model development: Use of a biocompatible thiolated hyaluronic acid biomaterial for the treatment of corneal epithelial wounds

Gina L Griffith; Barbara M Wirostko; Hee-Kyoung Lee; David O Zamora; Anthony James Johnson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3089. doi:

ARVO Annual Meeting Abstract June 2015

A Novel Carboxymethylated Hyaluronic Acid Polymer for Sustained Drug Delivery to Ocular Surface

Hee-Kyoung Lee; Michael Onorato; Isaac Erickson; MaryJane Rafii; McKenna MARIE Drysdale; Brittany Coats; Thomas Zarembinski; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4139. doi:

ARVO Annual Meeting Abstract June 2015

Formulation and Release of sd-rxRNA® from a Cross-linked, Thiolated CMHA-based Film for Topical Delivery to Reduce the Formation of Corneal Scarring

Michael Byrne; Hee-Kyoung Lee; James Cardia; Lakshmipathi Pandarinathan; Katherine Holton; Karen Bulock; Pamela A Pavco; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4143. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal tolerance and ocular pharmacokinetics in nonhuman primates of a carboxymethylated hyaluronic acid/polyethylene glycol diacrylate polymer useful for sustained drug delivery

MaryJane Rafii; Alex Lewis; Jordan Attwood; Vernard Woodley; Shervin Liddie; Wenzheng Hu; Robin J Goody; Matthew S Lawrence; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4166. doi:

ARVO Annual Meeting Abstract June 2015

Mechanical Properties of Four Carboxymethylated Hyaluronic Acid Hydrogel Polymer Formulations

Brittany Coats; McKenna MARIE Drysdale; Hee-Kyoung Lee; Barbara M Wirostko

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4167. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Evaluation of Risk Factors for Pseudoexfoliation and Progression to Glaucoma: A Longitudinal Epidemiological Study

Topical Cross-Linked HA-Based Hydrogel Accelerates Closure of Corneal Epithelial Defects and Repair of Stromal Ulceration in Companion Animals

The effect of crosslinked CMHA-S gel drops on in vivo corneal chemical burns

Efficacy and safety of an Iontophoresis platform to control post cataract inflammation and pain

Finite-element design of a carboxymethylated hyaluronic acid (CMHA-S) ocular bandage

Risk of inguinal hernia (IH) is increased in male patients with exfoliation syndrome: The Utah Project on Exfoliation Syndrome (UPEXS).

Carboxymethylated Hyaluronic acid (CMHA-S)-based Ocular Delivery of Antibiotics

Sustained Retinal Concentrations of OHR3031 Achieved with Intravitreal Injection of a Biodegradable Microparticle Formulation to Rabbits

Crosslinked carboxymethylated hyaluronic acid (CMHA-S)-based ocular sustained delivery of antibiotics

Design optimization to improve retention of a carboxymethylated hyaluronic acid (CMHA-S) drug-delivery device

Human growth hormone released from a biocompatible hyaluronic acid biomaterial modulates wound healing in an in vivo corneal chemical burn model

Association of Pelvic Organ Prolapse (POP) and Exfoliation Syndrome in Utah Medicare Beneficiaries

Assessing ocular hyaluronidase to develop a hyaluronan-based polymer drug delivery platform

Safety Assessment of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl Hyaluronic Acid (CMHA) Polymer in a Rabbit Ocular Surface Model.

Sustained Delivery of rHGH via a Novel, Biodegradable, Hyaluronic Acid (HA) Polymer Film

Model development: Use of a biocompatible thiolated hyaluronic acid biomaterial for the treatment of corneal epithelial wounds

A Novel Carboxymethylated Hyaluronic Acid Polymer for Sustained Drug Delivery to Ocular Surface

Formulation and Release of sd-rxRNA® from a Cross-linked, Thiolated CMHA-based Film for Topical Delivery to Reduce the Formation of Corneal Scarring

Intravitreal tolerance and ocular pharmacokinetics in nonhuman primates of a carboxymethylated hyaluronic acid/polyethylene glycol diacrylate polymer useful for sustained drug delivery

Mechanical Properties of Four Carboxymethylated Hyaluronic Acid Hydrogel Polymer Formulations

To View More...

You must be signed into an individual account to use this feature.